WHO Immunization Implementation Guide
0.2.0 - ci-build
WHO Immunization Implementation Guide, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations/ and changes regularly. See the Directory of published versions
Official URL: http://smart.who.int/immunizations/ValueSet/IMMZ.D.Observation | Version: 0.2.0 | |||
Active as of 2025-08-08 | Computable Name: IMMZ_D_Observation |
ValueSet for Observation codes for IMMZ.D
References
http://smart.who.int/immunizations/CodeSystem/IMMZ.D
Code | Display | Definition |
DE263 | Birth dose | Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen |
DE203 | Completed the primary vaccination series | Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen |
DE257 | Completed the booster series | Indicates if the client has completed the booster series of a product/antigen |
DE242 | Date when primary vaccination series was completed | The date when the client completed the primary vaccination series (per product/antigen) |
DE204 | HIV status | The current HIV status of the client |
DE208 | Preterm birth | The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks |
DE209 | Immunocompromised | The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases |
DE210 | Currently on ART | The client is currently receiving antiretroviral therapy (ART) |
DE243 | Type of TB infection test performed | The type of tuberculosis (TB) infection test performed |
DE246 | TB infection test result | Records the result of the TB infection test |
DE249 | Immunologically stable | The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines |
DE250 | Clinically well | The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging |
DE211 | Birth weight in grams | Represents the client's birth weight value measures in grams |
DE215 | ART start date | The date on which the client started or restarted ART |
DE251 | High risk of pneumococcal infection | The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease) |
DE236 | Age in months when client received first meningococcal dose | The age in months when client received their first meningococcal dose |
DE240 | VNA level | Vaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV) |
DE253 | Risk of occupational exposure to rabies virus | Professional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies |
DE241 | Dengue serostatus | Indicates the result of a serological test determining whether the client has antibodies against the dengue virus |
DE201 | Contact date | The date and time of the client's contact |
DE202 | ANC contact number | The antenatal care (ANC) contact or visit number |
This value set expansion contains 21 concepts.
Code | System | Display | Definition |
DE263 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Birth dose | Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen |
DE203 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Completed the primary vaccination series | Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen |
DE257 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Completed the booster series | Indicates if the client has completed the booster series of a product/antigen |
DE242 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Date when primary vaccination series was completed | The date when the client completed the primary vaccination series (per product/antigen) |
DE204 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | HIV status | The current HIV status of the client |
DE208 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Preterm birth | The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks |
DE209 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Immunocompromised | The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases |
DE210 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Currently on ART | The client is currently receiving antiretroviral therapy (ART) |
DE243 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Type of TB infection test performed | The type of tuberculosis (TB) infection test performed |
DE246 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | TB infection test result | Records the result of the TB infection test |
DE249 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Immunologically stable | The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines |
DE250 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Clinically well | The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging |
DE211 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Birth weight in grams | Represents the client's birth weight value measures in grams |
DE215 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | ART start date | The date on which the client started or restarted ART |
DE251 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | High risk of pneumococcal infection | The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease) |
DE236 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Age in months when client received first meningococcal dose | The age in months when client received their first meningococcal dose |
DE240 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | VNA level | Vaccine-induced neutralizing antibody (VNA) level, measured as a serum antibody concentration from the result of the concentrated, purified cell culture-derived and embryonated egg-based rabies vaccines (CCEEV) |
DE253 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Risk of occupational exposure to rabies virus | Professional at risk of occupational exposure to rabies virus, particularly animal health workers. Also considered for medical professionals who regularly provide care to persons with rabies |
DE241 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Dengue serostatus | Indicates the result of a serological test determining whether the client has antibodies against the dengue virus |
DE201 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Contact date | The date and time of the client's contact |
DE202 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | ANC contact number | The antenatal care (ANC) contact or visit number |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |